Meet a Scientist
Francesca Marassi, Ph.D.
Professor, Cancer Metabolism and Signaling Networks Program
Our path starts here
Join us on our journey as we drive scientific research to improve patient treatments for tomorrow.
Cancer
The Institute’s Cancer Center is one of only seven NCI-designated basic cancer research centers in the nation. We couple fundamental biological research with early translational studies to find new, innovative therapies that restore hope to cancer patients and their families.
Meet a Scientist
Garth Powis, D. Phil.
Jeanne and Gary Herberger Leadership Chair in Cancer Research
Disorders of Metabolism
The Center for Metabolic Origins of Disease studies common diseases that have reached pandemic scale including obesity, type 2 diabetes and cardiovascular complications. We have established an exciting environment that promotes multi-disciplinary discovery research toward breakthrough preventive and therapeutic strategies.
Meet a Scientist
Laszlo Nagy, M.D., Ph.D.
Director and Professor, Genomic Control of Metabolism Program
Immunity
The human immune system is made up of a network of cells, tissues and organs that fight off disease. It can also turn against the body causing autoimmune disorders, such as rheumatoid arthritis, lupus, Crohn’s disease and psoriasis. Increasingly, scientists are learning how to help the body’s immune system to combat cancer.
Meet a Scientist
Adam Godzik, Ph.D.
Director and Professor, Bioinformatics and Structural Biology Program
Meet a Scientist
Alex Strongin, Ph.D., D.Sci.
Professor, Bioinformatics and Structural Biology Program
Neuroscience and Aging
Diseases associated with aging and development are already a leading cause of death and disability, and their prevalence is rising fast—to give one example, by 2050, the number of Alzheimer’s patients age 65 and older may nearly triple from 5 million to 13.8 million.
Meet a Scientist
Rolf Bodmer, Ph.D.
Director and Professor, Development, Aging and Regeneration Program
Meet a Scientist
Huaxi Xu, Ph.D.
Jeanne and Gary Herberger Leadership Chair in Neuroscience Research
Sanford Children's Health Research Center
Genetic diseases in children are rare, and often incurable. Research insights into the genes and environmental factors that play a role in the development of childhood diseases are leading to better ways to more accurately diagnose, treat and cure children with disease.
Cancer
The Institute’s Cancer Center is one of only seven NCI-designated basic cancer research centers in the nation. We couple fundamental biological research with early translational studies to find new, innovative therapies that restore hope to cancer patients and their families.
Meet a Scientist
Francesca Marassi, Ph.D.
Professor, Cancer Metabolism and Signaling Networks Program
Meet a Scientist
Garth Powis, D. Phil.
Jeanne and Gary Herberger Leadership Chair in Cancer Research
Disorders of Metabolism
The Center for Metabolic Origins of Disease studies common diseases that have reached pandemic scale including obesity, type 2 diabetes and cardiovascular complications. We have established an exciting environment that promotes multi-disciplinary discovery research toward breakthrough preventive and therapeutic strategies.
Meet a Scientist
Laszlo Nagy, M.D., Ph.D.
Director and Professor, Genomic Control of Metabolism Program
Immunity
The human immune system is made up of a network of cells, tissues and organs that fight off disease. It can also turn against the body causing autoimmune disorders, such as rheumatoid arthritis, lupus, Crohn’s disease and psoriasis. Increasingly, scientists are learning how to help the body’s immune system to combat cancer.
Meet a Scientist
Adam Godzik, Ph.D.
Director and Professor, Bioinformatics and Structural Biology Program
Meet a Scientist
Alex Strongin, Ph.D., D.Sci.
Professor, Bioinformatics and Structural Biology Program
Neuroscience and Aging
Diseases associated with aging and development are already a leading cause of death and disability, and their prevalence is rising fast—to give one example, by 2050, the number of Alzheimer’s patients age 65 and older may nearly triple from 5 million to 13.8 million.
Meet a Scientist
Huaxi Xu, Ph.D.
Jeanne and Gary Herberger Leadership Chair in Neuroscience Research
Meet a Scientist
Rolf Bodmer, Ph.D.
Director and Professor, Development, Aging and Regeneration Program
Sanford Children's Health Research Center
Genetic diseases in children are rare, and often incurable. Research insights into the genes and environmental factors that play a role in the development of childhood diseases are leading to better ways to more accurately diagnose, treat and cure children with disease.
Drug Discovery and Technology
SBP has the talent and resources to accelerate the development of new therapeutics.
Prebys Center
Through development and application of modern drug discovery technologies, SBP is uniquely positioned to make next-generation medicines.
Translational Medicine Accelerator
The TMA identifies and advances lab discoveries with the greatest potential to address unmet clinical needs.
Other Platforms
SBP innovates and maintains key technologies and expertise to facilitate research.
Prebys Center
Through development and application of modern drug discovery technologies, SBP is uniquely positioned to make next-generation medicines.
Translational Medicine Accelerator
The TMA identifies and advances lab discoveries with the greatest potential to address unmet clinical needs.
Other Platforms
SBP innovates and maintains key technologies and expertise to facilitate research.
In the News
April 20, 2018
Mounting toll of Alzheimer's in lives, dollars in San Diego spelled out in reports
Press Release
April 20, 2018
San Diego leaders, researchers announce milestone grant as Alzheimer's crisis widens
Paper of the Week
Adipocyte p62/SQSTM1 Suppresses Tumorigenesis through Opposite Regulations of Metabolism in Adipose Tissue and Tumor
Beaker Blog March 20, 2018
Inaugural SBP Insights speaker series highlights prostate cancer
Read more
Beaker Blog March 19, 2018
Cancer immunology symposium highlights hot area in cancer research
Read more
200K
In the U.S., there are more than 200,000 cases of brain injuries each year. Our scientists are working on innovative drugs to treat brain injuries.
Support us
Your support is vital to accelerating scientific discoveries to improve human health. You can be a hero!